{
  "pmcid": "11065504",
  "sha256": "fe7f583dd0d1125fa7e220e806bfbd2333a4aeb49eb3890ee3064f21a92af731",
  "timestamp_utc": "2025-11-09T15:14:47.510364+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 14.42566037735849,
    "reading_ease": 20.683635703918753,
    "word_count": 212
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "We enrolled 36 patients"
      },
      "Participants": {
        "score": 2,
        "evidence": "Patients with locally advanced resectable esophageal/GEJ adenocarcinoma"
      },
      "Intervention": {
        "score": 2,
        "evidence": "Patients with locally advanced resectable esophageal/GEJ adenocarcinoma received PET directed chemoradiation with durvalumab prior to esophagectomy."
      },
      "Objective": {
        "score": 1,
        "evidence": "To determine the safety and efficacy of adding the anti-PD-1 antibody durvalumab to induction FOLFOX and preoperative chemotherapy in locally advanced esophageal adenocarcinoma."
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "The primary endpoint of the study was pathologic complete response (pCR)."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "We enrolled 36 patients"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "33 of whom completed all preoperative treatment and underwent surgery."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "pCR was identified in 8 (22% [one-sided 90% lower bound: 13.3%]) patients with mPR in 22 (61% [one sided 90% lower bound: 50%]) patients."
      },
      "Harms": {
        "score": 1,
        "evidence": "Preoperative treatment was well tolerated, with no delays to surgery nor new safety signals."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 12,
    "max_score": 25
  }
}